Beijing Succeeder Technology Past Earnings Performance
Past criteria checks 2/6
Beijing Succeeder Technology has been growing earnings at an average annual rate of 15.8%, while the Medical Equipment industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 6% per year. Beijing Succeeder Technology's return on equity is 7.4%, and it has net margins of 42.4%.
Key information
15.8%
Earnings growth rate
9.3%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | 6.0% |
Return on equity | 7.4% |
Net Margin | 42.4% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Beijing Succeeder Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 285 | 121 | 54 | 20 |
31 Dec 23 | 275 | 117 | 51 | 19 |
30 Sep 23 | 269 | 114 | 50 | 18 |
30 Jun 23 | 264 | 117 | 49 | 17 |
31 Mar 23 | 246 | 112 | 45 | 16 |
31 Dec 22 | 229 | 104 | 43 | 16 |
30 Sep 22 | 240 | 109 | 44 | 15 |
30 Jun 22 | 235 | 103 | 46 | 14 |
31 Mar 22 | 238 | 96 | 47 | 14 |
31 Dec 21 | 240 | 97 | 48 | 15 |
30 Sep 21 | 235 | 96 | 46 | 14 |
30 Jun 21 | 234 | 86 | 45 | 14 |
31 Mar 21 | 241 | 85 | 43 | 14 |
31 Dec 20 | 222 | 69 | 42 | 13 |
30 Sep 20 | 222 | 63 | 44 | 14 |
30 Jun 20 | 220 | 66 | 43 | 14 |
31 Mar 20 | 207 | 59 | 45 | 13 |
31 Dec 19 | 230 | 71 | 45 | 13 |
31 Dec 18 | 200 | 57 | 40 | 12 |
31 Dec 17 | 157 | 29 | 42 | 12 |
Quality Earnings: 688338 has a high level of non-cash earnings.
Growing Profit Margin: 688338's current net profit margins (42.4%) are lower than last year (45.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688338's earnings have grown by 15.8% per year over the past 5 years.
Accelerating Growth: 688338's earnings growth over the past year (7.4%) is below its 5-year average (15.8% per year).
Earnings vs Industry: 688338 earnings growth over the past year (7.4%) exceeded the Medical Equipment industry 1%.
Return on Equity
High ROE: 688338's Return on Equity (7.4%) is considered low.